Follow-The-Filings

Security · featured owners

SLS

Sellas Life Sciences Group I COM NEW Equity among managers we track

  • 1 exit

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0% Exit 0.00 pp 40,000 $169K hist

0 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.00 — —
Gross profit — — —
Gross margin — — —
Net income -$37.34M -$30.88M -$26.86M
Net margin — — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.17M $16.33M $75.21M
Total non-current assets * $3.05M $3.1M $3.13M
Total assets $6.22M $19.43M $78.34M
Total current liabilities $13.74M $9.51M $7.02M
Total non-current liabilities * $460,000 $457,000 $457,000
Total equity -$7.98M $9.46M $70.87M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$31.41M -$35.4M -$28.39M
Cash from investing -$5.5M $0.00 —
Cash from financing $22.32M $46.76M $86.3M
Net change in cash -$14.6M $11.36M $57.91M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders

26Q1

period archive